Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

André Schmidt

27 indexed publications match this author name.

ORCID: 0000-0001-6055-8397
OpenAlex: https://openalex.org/A5126523760

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 12 Receptor Pharmacology 12 Anxiety 9 Mechanism of Action 7 Observational Study 7 Consciousness 7 Brain Imaging 5 Mystical Experience 5 Review Article 4 Emotional Processing 4 Treatment-Resistant Depression 3 End-of-Life Distress 3

Journals

PsyArXiv 3 Research Square 2 bioRxiv 2 Universität Zürich, ZORA 1 edoc Publication server (Humboldt University of Berlin) 1 Med 1 Neuromodulation Technology at the Neural Interface 1 Fortschritte der Neurologie · Psychiatrie 1

Publication history

Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons.Unknown journal · 2026-03-26 Psilocin fosters neuroplasticity in iPSC-derived human cortical neuronsResearch Square · 2026-01-06 Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch NegativitybioRxiv · 2025-11-06 Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigmUniversität Zürich, ZORA · 2025-11-04 Akzeptanz psilocybin-assistierter Therapie in den deutschsprachigen Ländernedoc Publication server (Humboldt University of Berlin) · 2025-02-11 The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsPsyArXiv · 2024-10-21 Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch NegativityResearch Square · 2024-09-25 Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13 The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of ConsciousnessPsyArXiv · 2023-06-03 ID: 212703 Augmenting rTMS With Psilocybin-Assisted Psychotherapy (PAP) for PTSD: A Proof-of-Concept Study DesignNeuromodulation Technology at the Neural Interface · 2023-05-31 The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics.Unknown journal · 2023-05-28 [Attitudes of Mental Health Experts Towards Psilocybin].Fortschritte der Neurologie · Psychiatrie · 2022-06-19 Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).PLoS ONE · 2022-03-15 Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy.Unknown journal · 2021-07-22 Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)PsyArXiv · 2021-04-01 Dose-response relationships of psilocybin-induced subjective experiences in humans.Unknown journal · 2021-03-03 How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humansbioRxiv · 2020-06-10 [Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].Unknown journal · 2017-06-30 Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.Journal of Psychopharmacology · 2016-11-30 The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.NeuroImage Clinical · 2015-08-21 Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?Journal of psychopharmacology (Oxford, England) · 2015-02-28 Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.Cerebral Cortex · 2013-07-15 Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.Journal of Neuroscience · 2013-05-31 Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual HallucinationsOpen MIND · 2012-12-31 The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.Psychopharmacology · 2012-07-26 Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.Biological Psychiatry · 2012-05-09 Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.Unknown journal · 2011-10-25

Author directory